"He went through six operations and was placed on a clinical trial so he could try new treatments.”
A trial of radiotherapy with or without chemotherapy after surgery for oligodendroglioma brain tumours (EORTC 26951)
Doctors often treat oligodendroglioma brain tumours with surgery and radiotherapy. Many people also have a combination of chemotherapy called PCV to try to stop their cancer coming back. PCV is procarbazine, lomustine, and vincristine.
The aims of this trial were to find out
- If having radiotherapy and chemotherapy after surgery is better than having radiotherapy alone
- More about the side effects
Summary of results
The trial team found that PCV was not a useful treatment for people with oligodendroglioma brain tumours after surgery and radiotherapy.
368 people took part in this trial. After surgery
- Half had radiotherapy
- Half had radiotherapy and chemotherapy (PCV)
The researchers analysed the results in 2008. They compared the 2 groups. In the PCV group it took longer before there were any signs of the cancer getting worse. But overall they found no difference in how many people lived for 5 years after treatment.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Dr Martin J. Van den Bent
European Organisation for Research and Treatment of Cancer (EORTC)
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer